Loading clinical trials...
Loading clinical trials...
By 2020, lung cancer continues leading the first cause of cancer mortality and the second most common type of cancer in the world. There are limitations to early detection and then more than 60% of pa...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Instituto Nacional de Cancerologia, Columbia
Collaborators
NCT02688894 · Small Cell Lung Cancers, Neuroendocrine Carcinoma
NCT06816121 · Lung Cancers
NCT06810375 · Lung Cancers
NCT07219251 · Lung Cancer (NSCLC), Lung Adenocarcinoma, and more
NCT05857995 · Lung Cancer, Pulmonary Neoplasm, and more
Instituto Nacional de Cancerologia
Bogota, Cundinamarca
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions